4.6 Article

Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR

Journal

CELLS
Volume 10, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/cells10102646

Keywords

SARS-CoV-2; T cells; epitope presentation; public TCR recognition; YLQ peptide; COVID-19 recovered

Categories

Funding

  1. Monash University
  2. La Trobe University
  3. Australian Nuclear Science and Technology Organisation (ANSTO)
  4. Australian Nuclear Science and Technology Organisation (AINSE ECR grants)
  5. Australian Nuclear Science and Technology Organisation (AINSE PGRA)
  6. Australian Research Council (ARC)
  7. National Health and Medical Research Council (NHMRC)
  8. Medical Research Future Fund (MRFF)
  9. Monash Biomedicine Institute PhD scholarship
  10. AINSE Ltd. Postgraduate Research Award (PGRA)
  11. NHMRC CJ Martin Fellowship [1110429]
  12. Australian Research Council DECRA [DE210101479]
  13. NHMRC SRF [1159272]
  14. National Health and Medical Research Council of Australia [1159272, 1110429] Funding Source: NHMRC
  15. Australian Research Council [DE210101479] Funding Source: Australian Research Council

Ask authors/readers for more resources

The study presents the crystallography structure of T cell receptor binding with a SARS-CoV-2 epitope, demonstrating the activation of CD8+ T cell response in COVID-19 patients and providing insights into TCR recognition mechanisms.
The data currently available on how the immune system recognises the SARS-CoV-2 virus is growing rapidly. While there are structures of some SARS-CoV-2 proteins in complex with antibodies, which helps us understand how the immune system is able to recognise this new virus; however, we lack data on how T cells are able to recognise this virus. T cells, especially the cytotoxic CD8+ T cells, are critical for viral recognition and clearance. Here we report the X-ray crystallography structure of a T cell receptor, shared among unrelated individuals (public TCR) in complex with a dominant spike-derived CD8+ T cell epitope (YLQ peptide). We show that YLQ activates a polyfunctional CD8+ T cell response in COVID-19 recovered patients. We detail the molecular basis for the shared TCR gene usage observed in HLA-A*02:01+ individuals, providing an understanding of TCR recognition towards a SARS-CoV-2 epitope. Interestingly, the YLQ peptide conformation did not change upon TCR binding, facilitating the high-affinity interaction observed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available